Related references
Note: Only part of the references are listed.Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption
Phillip W. Janowicz et al.
BIOMATERIALS (2022)
Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
Malcolm Lim et al.
CANCERS (2022)
Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site Barrier
Brandon M. Bordeau et al.
FRONTIERS IN PHARMACOLOGY (2022)
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Malcolm Lim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2022)
Modulating Macrophage Clearance of Nanoparticles: Comparison of Small-Molecule and Biologic Drugs as Pharmacokinetic Modifiers of Soft Nanomaterials
Jessica A. Mills et al.
MOLECULAR PHARMACEUTICS (2022)
Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance
N. L. Fletcher et al.
CHEMICAL COMMUNICATIONS (2022)
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast Cancer
Mirat Shah et al.
CLINICAL CANCER RESEARCH (2021)
The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis
Markus Kuksis et al.
NEURO-ONCOLOGY (2021)
DNA Repair Pathways in Cancer Therapy and Resistance
Lan-ya Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications
Si-qi Zhang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)
Volkmar Mueller et al.
EUROPEAN JOURNAL OF CANCER (2021)
Defining body-weight reduction as a humane endpoint: a critical appraisal
Steven R. Talbot et al.
LABORATORY ANIMALS (2020)
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
R. K. Murthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace et al.
CIRCULATION RESEARCH (2020)
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies
Zachary H. Houston et al.
ACS CENTRAL SCIENCE (2020)
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting
Amal J. Sivaram et al.
ACS NANO (2020)
Investigation of the Therapeutic Potential of a Synergistic Delivery System through Dual Controlled Release of Camptothecin-Doxorubicin
Yongmei Zhao et al.
ADVANCED THERAPEUTICS (2020)
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
Malcolm Lim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies
Jiwei Cui et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Theranostic Strategy of Focused Ultrasound Induced Blood-Brain Barrier Opening for CNS Disease Treatment
Ko-Ting Chen et al.
FRONTIERS IN PHARMACOLOGY (2019)
Nanoparticles Surmounting Blood-Brain Tumor Barrier Through Both Transcellular and Paracellular Pathways to Target Brain Metastases
Tongtong Miao et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Issues with Fertility in Young Women with Breast Cancer
Nicole Christian et al.
CURRENT ONCOLOGY REPORTS (2019)
LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases
Qian Guo et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
B. R. Loman et al.
SCIENTIFIC REPORTS (2019)
APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
Casey D. Stefanski et al.
NEOPLASIA (2019)
Cancer Treatment-Related Infertility: A Critical Review of the Evidence
Philip D. Poorvu et al.
JNCI CANCER SPECTRUM (2019)
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study
Rashmi Murthy et al.
LANCET ONCOLOGY (2018)
Applications of nanoparticle systems in drug delivery technology
Syed A. A. Rizvi et al.
SAUDI PHARMACEUTICAL JOURNAL (2018)
Effect of VH-VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding
Wei-Li Ling et al.
FRONTIERS IN IMMUNOLOGY (2018)
Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer
Daniel N. Cagney et al.
JAMA ONCOLOGY (2018)
Designed multifunctional polymeric nanomedicines: long-term biodistribution and tumour accumulation of aptamer-targeted nanomaterials
N. L. Fletcher et al.
CHEMICAL COMMUNICATIONS (2018)
Distinction Between Active and Passive Targeting of Nanoparticles Dictate Their Overall Therapeutic Efficacy
Tristan D. Clemons et al.
LANGMUIR (2018)
Effects of Surface Charge of Hyperbranched Polymers on Cytotoxicity, Dynamic Cellular Uptake and Localization, Hemotoxicity, and Pharmacokinetics in Mice
Liyu Chen et al.
MOLECULAR PHARMACEUTICS (2017)
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
David P. Kodack et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Doxorubicin Has Dose-Dependent Toxicity on Mouse Ovarian Follicle Development, Hormone Secretion, and Oocyte Maturation
Shuo Xiao et al.
TOXICOLOGICAL SCIENCES (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice
Wayne J. Aston et al.
BMC CANCER (2017)
Cancer-treatment-induced neurotoxicity - focus on newer treatments
Jacqueline B. Stone et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Nazila Kamaly et al.
CHEMICAL REVIEWS (2016)
Targeted Therapies for Brain Metastases from Breast Cancer
Vyshak Alva Venur et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
Nazanin Hoshyar et al.
NANOMEDICINE (2016)
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Christopher B. Howard et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Expression Pattern of Mouse Vasa Homologue (MVH) in the Ovaries of C57BL/6 Female Mice
Kunkun Song et al.
MEDICAL SCIENCE MONITOR (2016)
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
Jodi M. Saunus et al.
JOURNAL OF PATHOLOGY (2015)
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration
Yong-Bo Hu et al.
TRANSLATIONAL NEURODEGENERATION (2015)
IMGT®, the international ImMunoGeneTics information system® 25 years on
Marie-Paule Lefranc et al.
NUCLEIC ACIDS RESEARCH (2015)
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
S. M. Swain et al.
ANNALS OF ONCOLOGY (2014)
HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+breast cancer
Andrew R. Green et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay
Fabricio F. T. Barros et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Chk2 Phosphorylation of Survivin-ΔEx3 Contributes to a DNA Damage-Sensing Checkpoint in Cancer
Alessia Lopergolo et al.
CANCER RESEARCH (2012)
Anionic Polyelectrolyte-Stabilized Nanoparticles via RAFT Aqueous Dispersion Polymerization
M. Semsarilar et al.
LANGMUIR (2012)
Efflux Pump-Mediated Resistance in Chemotherapy
P. O. Ughachukwu et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2012)
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
Chunbai He et al.
BIOMATERIALS (2010)
Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
Paul R. Lockman et al.
CLINICAL CANCER RESEARCH (2010)
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
Leonard Da Silva et al.
BREAST CANCER RESEARCH (2010)
Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
Birgit Schoeberl et al.
SCIENCE SIGNALING (2009)
Cancer and fertility preservation: fertility preservation in breast cancer patients
Theodoros Maltaris et al.
BREAST CANCER RESEARCH (2008)
Targeting HER proteins in cancer therapy and the role of the non-target HER3
A. C. Hsieh et al.
BRITISH JOURNAL OF CANCER (2007)
Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors
Carsten Nieder et al.
RADIATION ONCOLOGY (2006)
Cardiotoxicity of cytotoxic drugs
KJM Schimmel et al.
CANCER TREATMENT REVIEWS (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
The role of chemotherapy in brain metastases
MJ van den Bent
EUROPEAN JOURNAL OF CANCER (2003)
Osmotic opening of the blood-brain barrier: Principles, mechanism, and therapeutic applications
SI Rapoport
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Share Paper
